VREX vareximaging.com: Forward P/S Multiple

The forward EV/Revenue ratio demonstrates the asset's valuation dynamics, with the value fixed at 0.40. Varex Imaging (VREX) supplies X-ray components for security and medical systems, dominating the tubes and detectors segment. Revenues depend on equipment upgrade cycles, which creates moderate volatility. Results rely on CT scanner orders, requiring strict inventory control to maintain margins.

vareximaging.com - VREX Market Cap to Expected Sales Ratio (period 07/04/2022 - 11/13/2026)

Metric breakdowns and analytics for Varex Imaging Corp. (VREX)

- current price and projected stock value:

Stock Price Varex Imaging Corporation|VREX - Average Forecast Price

- company stock capitalization data:

Market Capitalization Varex Imaging Corp.|VREX - Business Value

- issuer book value statistics:

Book Value per Share Varex Imaging|VREX - Book Valuation of Business|Market Capitalization to Book Value Ratio vareximaging.com|VREX - Cumulative Company Assets

- company total debt and liquidity indicators:

- financial results and valuation multiples details:

VREX - Annual Net Income|Future Profit Varex Imaging|VREX - P/E Multiple|Forward P/E Multiple Varex|VREX - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Varex Imaging Corp.|VREX - Profit before deduction of interest, taxes, depreciation and amortization|Earnings per share for the last twelve months Varex Imaging|VREX - Net earnings per share for the last 12 months|Quarterly EPS earnings growth vareximaging.com|VREX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Varex Imaging

- sales volume and revenue indicators:

VREX - Company Sales Volume|Company Future Sales Volume Varex Imaging Corporation|VREX - Market Cap to Sales Volume|Forward Price-to-Revenue Multiple Varex Imaging Corp.

Summary company analytics:Varex Imaging Corporation (VREX)

To assess the long-term risks of Varex Imaging (VREX), it is essential to monitor market expectations regarding business capitalization. This indicator is calculated by dividing the company's current value by its projected revenue, reflecting the valuation's sensitivity to inflationary shocks. By analyzing the expected price-to-sales ratio, an investor can determine the speed at which the market revises the multiple. The technological indispensability of Varex Imaging (VREX) components in medical devices curbs the volatility of this metric, protecting share prices from dumping.

Key competitors

Forward P/S Multiple ABT (Abbott)|Thermo Fisher Scientific Inc. (TMO) - Market Cap to Future Revenue Ratio|GE Healthcare Corp - Forward P/S Multiple|MTD (Mettler Toledo Inc) - Market Cap to Projected Revenue|WAT: Forward P/S Multiple|TECH - Market Cap to Expected Sales Ratio|BRKR (Bruker) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Azenta Inc (AZTA)|Forward P/S Multiple SMLR|Forward P/S Multiple Butterfly Corp (BFLY)|Price-to-Projected Revenue Ratio Mesa Laboratories, Inc. MLAB|quantum-si.com - Price-to-Projected Revenue Ratio|NNOX: Forward Price-to-Revenue Multiple|Forward Price to Sales QTRX (Quanterix Corp.)|MASS: Forward P/S Multiple|Market Cap to Future Revenue Ratio CapsoVision (CV)|Price-to-Projected Revenue Ratio MaxCyte, Inc.|RPID - Projected Price to Revenue|Forward Price-to-Revenue Multiple SEER (Seer)|Forward P/S Multiple Hyperfine Inc (HYPR)|Forward P/S Multiple FONR (FONAR Corp)|Market Cap to Expected Sales Ratio Daxor Corp (DXR)|MDAI - Price-to-Projected Revenue Ratio|Future Price to Revenue VIVS|Aclarion, Inc. (ACON) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Akoya Biosciences, Inc.|THMO (ThermoGenesis Holdings Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Talis Biomedical Corp TLIS|Price-to-Projected Revenue Ratio T2 Biosystems, Inc. (TTOO)